The high analytical error rate in immunoassays is well documented, estimated to range from 0.4% to 4.0%. These errors generate misleading or even false results, and are caused in large part by interference from endogenous antibodies in sera. To account for this, many labs are forced to discard otherwise valuable sera samples due to elevated antibody titers. However, rather than wasting these samples, labs can take a proactive approach to adjust antibody concentration while preserving the biological context of the serum using antibody-free human serum.
Why high-titer serum creates challenges
Human serum contains a complex mixture of immunoglobulins, proteins, and complement components. When antibody levels are elevated, they can dominate assay behavior by:
- Competing with detection antibodies for binding sites
- Binding nonspecifically to assay components
- Amplifying background signal or masking true analyte levels
In practice, these challenges can lead to inaccurate data, complicating interpretation, delaying projects, and increasing the likelihood of sample exclusion or rework. Additionally, endogenous antibody interference is specific to each individual’s sera, meaning teams must account for variability across sera samples and batches.
The limitations of traditional dilution methods
A common approach to managing high-titer serum is dilution using a buffer. However, while this reduces antibody concentration, it also dilutes all other components of the sample, leading to:
- Altered protein composition
- Reduced complement activity
- Loss of biological context
- Matrix effects that impact assay performance
As a result, though buffer dilution may resolve high antibody concentration, it can introduce new challenges, particularly in assays that depend on a physiologically relevant serum environment.
Antibody-free human serum as a diluent matrix
Antibody-free or antibody-depleted human serum (ADHS)—serum from which specific immunoglobulins (IgG, IgM, and/or IgA) have been selectively removed, typically using affinity-based purification methods—offers a more controlled alternative. Rather than diluting serum with a non-biological buffer, ADHS provides a serum-based matrix, enabling labs to:
- Reduce overall antibody concentration
- Maintain key serum components such as proteins and complement
- Preserve the biological relevance of the sample environment
By using ADHS as a diluent matrix, teams can bring high-titer serum samples into a usable range while maintaining assay integrity. This enables more reliable quantification and reduces the need to discard otherwise valuable material.
Need a more targeted approach?
Custom immunodepletion can be tailored to remove specific antibody populations, helping refine high-titer samples for sensitive or assay-specific applications.
When to Use Antibody-Depleted Human Serum
ADHS supports assay development, validation, and quality control across a range of technical applications:
- Negative Immunoglobulin Controls (IgG/IgM): Used as antibody-negative control sera to establish baseline signal and reduce interference in antibody-sensitive assays.
- Quality Control and Assay Acceptance: Incorporated as internal positive or negative controls to support assay validation and monitor performance over time.
- Proficiency Testing Panels: Used in panel-based studies to evaluate assay consistency and monitor long-term performance across runs or laboratories.
- Critical Reagent Qualification: Applied in the qualification of key assay components—such as complement lots or bacterial banks—and to validate replacement materials.
- Dilution and Linearity Studies: Suitable as a diluent matrix for assessing assay linearity and performance across concentration ranges.
- False Positive Assessment: Used to generate antibody-negative serum samples for statistically determining false positive rates in assay systems.
Together, these applications make antibody-depleted human serum a versatile tool for improving assay accuracy, reducing variability, and supporting reliable, reproducible results across complex workflows.
Antibody-Depleted Human Sera Supplier Checklist
Making the most of every serum sample
Serum samples are often discarded not because they are of poor quality, but because they are not compatible with immunoassays. By using antibody-free human serum as a diluent matrix, labs can extend the usability of high-titer samples, reduce variability, and maintain the integrity of their workflows. In doing so, it becomes possible to get more value from every sample—without compromising performance or reliability.
About Pel-Freez Biologicals
Pel-Freez Biologicals provides a broad portfolio of high-quality biological products to support immunoassay development and research. This includes a range of serum, plasma, complement, and antibody-depleted products designed for consistency, performance, and reproducibility.
Our offering includes specialized reagents such as gamma globulins, antibody-depleted complement, and rabbit complement—all available to help meet the demands of complex assay workflows.
Contact our team to learn more about our products.
